Association of low birth weight and prematurity with clinical outcomes of childhood nephrotic syndrome: a prospective cohort study.


Journal

Pediatric nephrology (Berlin, Germany)
ISSN: 1432-198X
Titre abrégé: Pediatr Nephrol
Pays: Germany
ID NLM: 8708728

Informations de publication

Date de publication:
09 2019
Historique:
received: 31 08 2018
accepted: 29 03 2019
revised: 11 01 2019
pubmed: 13 4 2019
medline: 7 7 2020
entrez: 13 4 2019
Statut: ppublish

Résumé

Low birth weight (LBW)/prematurity have been proposed as risk factors for the development of kidney disease in adulthood. Whether there is an association between LBW/prematurity and poor renal outcomes in childhood onset nephrotic syndrome remains unknown. Children with nephrotic syndrome diagnosed between 1 and 18 years of age were followed prospectively from 1996 to 2016 at The Hospital for Sick Children (N = 377). LBW/prematurity was defined as birth weight < 2500 g or gestational age < 36 weeks. Normal birth weight (NBW) was defined as birth weight ≥ 2500 g. Measures evaluating clinical course of nephrotic syndrome include initial steroid-resistant nephrotic syndrome (SRNS), time to first relapse, and frequently relapsing nephrotic syndrome. Kaplan-Meier survival analysis, logistic regression, and Cox proportional hazards regression were used to determine the association of LBW/prematurity with clinical outcomes. Median birth weights in LBW/premature (n = 46) and NBW (n = 331) children were 2098 g (interquartile range [IQR] 1700-2325 g) and 3317 g (IQR 2977-3685 g), respectively. Odds of having SRNS were 3.78 (95% confidence interval [CI] 1.28-11.21) times higher among LBW/premature children than NBW children. An 8% decrease in odds of developing SRNS was observed for every 100 g increase in birth weight (adjusted odds ratio [OR] 0.92; 95% CI 0.86-0.98). Median time to first relapse did not differ (hazard ratio [HR] 0.89; 95% CI 0.53-1.16). LBW/premature children were more likely to develop SRNS but did not have a difference in time to first relapse with NBW children. Understanding the impact and mechanism of birth weight and steroid-resistant disease needs further study.

Sections du résumé

BACKGROUND
Low birth weight (LBW)/prematurity have been proposed as risk factors for the development of kidney disease in adulthood. Whether there is an association between LBW/prematurity and poor renal outcomes in childhood onset nephrotic syndrome remains unknown.
METHODS
Children with nephrotic syndrome diagnosed between 1 and 18 years of age were followed prospectively from 1996 to 2016 at The Hospital for Sick Children (N = 377). LBW/prematurity was defined as birth weight < 2500 g or gestational age < 36 weeks. Normal birth weight (NBW) was defined as birth weight ≥ 2500 g. Measures evaluating clinical course of nephrotic syndrome include initial steroid-resistant nephrotic syndrome (SRNS), time to first relapse, and frequently relapsing nephrotic syndrome. Kaplan-Meier survival analysis, logistic regression, and Cox proportional hazards regression were used to determine the association of LBW/prematurity with clinical outcomes.
RESULTS
Median birth weights in LBW/premature (n = 46) and NBW (n = 331) children were 2098 g (interquartile range [IQR] 1700-2325 g) and 3317 g (IQR 2977-3685 g), respectively. Odds of having SRNS were 3.78 (95% confidence interval [CI] 1.28-11.21) times higher among LBW/premature children than NBW children. An 8% decrease in odds of developing SRNS was observed for every 100 g increase in birth weight (adjusted odds ratio [OR] 0.92; 95% CI 0.86-0.98). Median time to first relapse did not differ (hazard ratio [HR] 0.89; 95% CI 0.53-1.16).
CONCLUSIONS
LBW/premature children were more likely to develop SRNS but did not have a difference in time to first relapse with NBW children. Understanding the impact and mechanism of birth weight and steroid-resistant disease needs further study.

Identifiants

pubmed: 30976899
doi: 10.1007/s00467-019-04255-1
pii: 10.1007/s00467-019-04255-1
doi:

Substances chimiques

Glucocorticoids 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1599-1605

Références

Lancet. 2003 Aug 23;362(9384):629-39
pubmed: 12944064
Arch Intern Med. 2000 May 22;160(10):1472-6
pubmed: 10826460
J Pediatr Gastroenterol Nutr. 2016 Dec;63(6):e193-e203
pubmed: 27019409
Am J Kidney Dis. 2014 Mar;63(3):354-62
pubmed: 24423782
Kidney Int. 2003 Jun;63(6):2113-22
pubmed: 12753298
Int J Nephrol. 2013;2013:346067
pubmed: 24073334
Am J Kidney Dis. 2001 May;37(5):909-14
pubmed: 11325671
Med Hypotheses. 2017 Oct;108:35-37
pubmed: 29055396
Pediatr Nephrol. 2007 Nov;22(11):1881-9
pubmed: 17874138
Pediatr Res. 2015 Jan;77(1-2):205-13
pubmed: 25310760
Pediatr Nephrol. 2015 Feb;30(2):221-33
pubmed: 24584664
Am J Nephrol. 2002 Sep-Dec;22(5-6):463-7
pubmed: 12381944
Pediatr Res. 2017 Dec;82(6):1000-1006
pubmed: 28846672
Kidney Int. 2000 Aug;58(2):770-3
pubmed: 10916101
Lancet. 1989 Sep 9;2(8663):577-80
pubmed: 2570282
BMC Nephrol. 2013 Jan 26;14:25
pubmed: 23351121
Clin Exp Nephrol. 2018 Feb;22(1):126-132
pubmed: 28643120
Clin J Am Soc Nephrol. 2016 Oct 7;11(10):1760-1768
pubmed: 27445165
Cochrane Database Syst Rev. 2016 Oct 11;10:CD003594
pubmed: 27726125
Am J Nephrol. 2018;47(3):164-170
pubmed: 29533950
Pediatr Transplant. 2007 Jun;11(4):366-73
pubmed: 17493215
Eur J Pediatr. 2016 May;175(5):685-93
pubmed: 26833050
Br J Obstet Gynaecol. 1987 Aug;94(8):731-5
pubmed: 3663531
Lancet. 2013 Jul 20;382(9888):273-83
pubmed: 23727166
Environ Epigenet. 2016 Aug 1;2(3):
pubmed: 28979800
Am J Hypertens. 1988 Oct;1(4 Pt 1):335-47
pubmed: 3063284
BMJ. 1990 Aug 4;301(6746):259-62
pubmed: 2390618
Pediatrics. 1976 Aug;58(2):259-63
pubmed: 951142
Am J Kidney Dis. 1996 Apr;27(4):484-8
pubmed: 8678057
Arch Dis Child. 2000 Mar;82(3):202-3
pubmed: 10685920
Kidney Int. 1998 Oct;54(4):1320-3
pubmed: 9767550
Pediatr Dev Pathol. 2004 Jan-Feb;7(1):17-25
pubmed: 15255031
J Trop Pediatr. 1997 Dec;43(6):345-8
pubmed: 9476456
Pediatr Nephrol. 1991 Jul;5(4):393-7
pubmed: 1911111
Nephrol Dial Transplant. 2008 May;23(5):1615-20
pubmed: 18065792

Auteurs

Natalia Konstantelos (N)

Child Health Evaluative Sciences, Research Institute, Hospital for Sick Children, 686 Bay St, Toronto, ON, M5G 0A4, Canada.
University of Toronto, 27 King's College Cir, Toronto, ON, M5S 3H7, Canada.

Tonny Banh (T)

Child Health Evaluative Sciences, Research Institute, Hospital for Sick Children, 686 Bay St, Toronto, ON, M5G 0A4, Canada.

Viral Patel (V)

University of Toronto, 27 King's College Cir, Toronto, ON, M5S 3H7, Canada.

Jovanka Vasilevska-Ristovska (J)

Child Health Evaluative Sciences, Research Institute, Hospital for Sick Children, 686 Bay St, Toronto, ON, M5G 0A4, Canada.

Karlota Borges (K)

Child Health Evaluative Sciences, Research Institute, Hospital for Sick Children, 686 Bay St, Toronto, ON, M5G 0A4, Canada.

Neesha Hussain-Shamsy (N)

University of Toronto, 27 King's College Cir, Toronto, ON, M5S 3H7, Canada.

Damien Noone (D)

University of Toronto, 27 King's College Cir, Toronto, ON, M5S 3H7, Canada.
Division of Nephrology, Hospital for Sick Children, 555 University Ave, Toronto, ON, M5G 1X8, Canada.

Diane Hebert (D)

University of Toronto, 27 King's College Cir, Toronto, ON, M5S 3H7, Canada.
Division of Nephrology, Hospital for Sick Children, 555 University Ave, Toronto, ON, M5G 1X8, Canada.

Seetha Radhakrishnan (S)

University of Toronto, 27 King's College Cir, Toronto, ON, M5S 3H7, Canada.
Division of Nephrology, Hospital for Sick Children, 555 University Ave, Toronto, ON, M5G 1X8, Canada.

Christoph P B Licht (CPB)

University of Toronto, 27 King's College Cir, Toronto, ON, M5S 3H7, Canada.
Division of Nephrology, Hospital for Sick Children, 555 University Ave, Toronto, ON, M5G 1X8, Canada.

Valerie Langlois (V)

University of Toronto, 27 King's College Cir, Toronto, ON, M5S 3H7, Canada.
Division of Nephrology, Hospital for Sick Children, 555 University Ave, Toronto, ON, M5G 1X8, Canada.

Rachel J Pearl (RJ)

University of Toronto, 27 King's College Cir, Toronto, ON, M5S 3H7, Canada.
Division of Nephrology, Hospital for Sick Children, 555 University Ave, Toronto, ON, M5G 1X8, Canada.
Department of Pediatrics, William Osler Health System, 101 Humber College Blvd, Etobicoke, ON, M9V 1R8, Canada.

Rulan S Parekh (RS)

Child Health Evaluative Sciences, Research Institute, Hospital for Sick Children, 686 Bay St, Toronto, ON, M5G 0A4, Canada. rulan.parekh@sickkids.ca.
University of Toronto, 27 King's College Cir, Toronto, ON, M5S 3H7, Canada. rulan.parekh@sickkids.ca.
Division of Nephrology, Hospital for Sick Children, 555 University Ave, Toronto, ON, M5G 1X8, Canada. rulan.parekh@sickkids.ca.
University Health Network, 101 College St, Toronto, ON, M5G 1L7, Canada. rulan.parekh@sickkids.ca.
Dalla Lana School of Public Health, University of Toronto, 155 College St, Toronto, ON, M5T 3M7, Canada. rulan.parekh@sickkids.ca.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH